用于针对MYC和KRAS的向降解的异构功能蛋白质仿真聚合物
Max M Wang1,2,3,4, Mihai I Truica5,6, Brayley S Gattis1,3,4
1Department of Chemistry, Northwestern University, Evanston, IL, USA.
Nature communications
|February 24, 2026
概括
我们开发了HYDRAC,这是一个用于向蛋白质降解 (TPD) 的新型聚合物平台. HYDRAC有效地降低了MYC和KRAS等具有挑战性的疾病目标,扩大了TPD应用.
科学领域:
- 生物化学 生物化学
- 聚合物化学 聚合物化学
- 分子生物学分子生物学
背景情况:
- 向蛋白降解 (TPD) 提供了一种调节以前无法调节的蛋白质的方法.
- 目前的小分子TPD方法面临着优化方面的挑战,并且需要在目标蛋白上特定的可结合口袋.
研究的目的:
- 引入混合降解聚合物 (HYDRAC) 平台,以克服当前TPD方法的局限性.
- 通过将目标结合和降解剂集成,证明HYDRAC具有选择性降解疾病相关蛋白质的能力.
主要方法:
- 开发了HYDRAC,一个模块化聚合物平台,允许各种目标结合基因和E3结合酶招募器 (VHL,KEAP1,CRBN) 的结合.
- 合成的HYDRACs适应可扩展的方法和结构性可调性.
- 使用HYDRAC来准Myelocytomatosis原瘤基因 (MYC) 和基尔斯大鼠肉瘤病毒瘤基因同源 (KRAS).
主要成果:
- 使用HYDRAC实现了MYC和KRAS在体外强大的降解.
- 在HYDRAC治疗后,在小鼠模型中证明了持久的瘤抑制.
- 在具有特定HYDRAC构造的多个等位基因中展示了泛-KRAS降解潜力.
结论:
- HYDRAC代表了一种多功能和可扩展的聚合物平台,用于向蛋白质降解.
- 这种方法显著扩大了TPD武器库,使得它能够准MYC和KRAS等历史上难以处理的蛋白质.
- 海德拉克技术有望开发针对各种疾病的新疗法.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Regulated Protein Degradation
9.0K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.0K
Conservative Site-specific Recombination and Phase Variation
6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.9K
Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
57
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
57


